Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/76163
Title: Managing advanced prostate cancer in the Asia Pacific region: “Real-world” application of Advanced Prostate Cancer Consensus Conference 2019 statements
Authors: Edmund Chiong
Declan G. Murphy
Nicholas C. Buchan
Melvin L.K. Chua
Lukman Hakim
Agus Rizal Hamid
Sung K. Hong
Lisa G. Horvath
Ravi Kanesvaran
Makarand Khochikar
Jason Letran
Bannakij Lojanapiwat
Rohan Malek
Anthony C.F. Ng
Nguyễn Tuấn Vinh
See Tong Pang
Darren M.C. Poon
Teng Aik Ong
Marniza Saad
Kathryn Schubach
Ryoichi Shiroki
Levent Türkeri
Scott Williams
Alvin Wong
Dingwei Ye
Ian D. Davis
Authors: Edmund Chiong
Declan G. Murphy
Nicholas C. Buchan
Melvin L.K. Chua
Lukman Hakim
Agus Rizal Hamid
Sung K. Hong
Lisa G. Horvath
Ravi Kanesvaran
Makarand Khochikar
Jason Letran
Bannakij Lojanapiwat
Rohan Malek
Anthony C.F. Ng
Nguyễn Tuấn Vinh
See Tong Pang
Darren M.C. Poon
Teng Aik Ong
Marniza Saad
Kathryn Schubach
Ryoichi Shiroki
Levent Türkeri
Scott Williams
Alvin Wong
Dingwei Ye
Ian D. Davis
Keywords: Medicine
Issue Date: 1-Jan-2022
Abstract: Aim: The second Asia-Pacific Advanced Prostate Cancer Consensus Conference (APAC APCCC 2020) gathered insights into the real-world application in the Asia-Pacific (APAC) region of consensus statements from the 3rd Advanced Prostate Cancer Consensus Conference (APCCC 2019). Methods: The 4-h our virtual meeting in October 2020 brought together 26 experts from 14 APAC countries to discuss APCCC 2019 recommendations. Presentations were prerecorded and viewed prior to the meeting. A postmeeting survey gathered views on current practice. Results: The meeting and survey highlighted several developments since APAC APCCC 2018. Increased access and use in the region of PSMA PET/CT imaging is providing additional diagnostic and staging information for advanced prostate cancer and influencing local and systemic therapy choices. Awareness of oligometastatic disease, although not clearly defined, is increasing. Novel androgen receptor pathway antagonists are expanding treatment options. Cost and access to contemporary treatments and technologies continue to be a significant factor influencing therapeutic decisions in the region. With treatment options increasing, multidisciplinary treatment planning, shared decision making, and informed choice remain critical. A discussion on the COVID-19 pandemic highlighted challenges for diagnosis, treatment, and clinical trials and new service delivery models that will continue beyond the pandemic. Conclusion: APAC-specific prostate cancer research and data are important to ensure that treatment guidelines and recommendations reflect local populations and resources. Facilitated approaches to collaboration across the region such as that achieved through APAC APCCC meetings continue to be a valuable mechanism to ensure the relevance of consensus guidelines within the region.
URI: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85133548760&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/76163
ISSN: 17437563
17437555
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.